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LC-ESI-MS and HPLC were used for the identification of the constituents from G. lutea leaves collected at different localities, as well as for quantification of 
the main compounds. Seven secoiridoids, five C-glucoflavones and three xanthones, were identified. Swertiamarin derivatives, namely eustomorusside (2), 
eustomoside (3) and septemfidoside (5), were detected in G. lutea for the first time. Concentrations of five constituents (swertiamarin, gentiopicrin, isovitexin, 
mangiferin and isogentisin) were determined. The relationship between concentrations of γ-pyrones and altitude was observed with statistically significant 
correlation (r = 0.94). The extracts were also evaluated for their content of total phenolics, and antiradical and cytotoxic activities. The total phenolics content 
ranged from 7.7 to 12.7 mg GAE/g, and the IC50 values for DPPH radical scavenging activity varied between 0.45 to 2.02 mg/mL. The leaf extract exhibited 
moderate cytotoxic effects toward HeLa cells with an IC50 value of 41.1 µg/mL, while gentiopicrin, mangiferin and isogentisin exerted strong activity against 
HeLa cells, with IC50 values ranging from 5.7 to 8.8 µg/mL. The results confirm the traditional usage of G. lutea leaves and also suggest their possible 
utilization as hepatoprotective, hypoglycemic and anti-inflammatory agents.  
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Leaves of yellow gentian (Gentiana lutea L., Gentianaceae) are far 
less used in folk medicine then roots, which have a long tradition of 
usage as a bitter tonic in gastrointestinal ailments in Central and 
Southeast Europe, particularly among populations of the mountain 
regions [1]. There are reports that the leaves are used as a substitute 
for gentian root in Serbia and some other countries of the Central 
Balkans [1,2]. In folk medicine of Belarus and Uzbekistan the 
leaves are used as an appetite stimulant and against stomach and 
intestinal colic [3]. Leaf extracts also possess hepatoprotective 
properties, stimulating the liver and repairing its structure [4]. There 
are also reports that leaves are used in conditions connected with 
malignant diseases of the digestive tract [5]. 
 
Several studies report the phytochemical composition of the aerial 
parts of G. lutea [6,7], and one describes the simultaneous 
determination of secoiridoids, flavonoids and xanthones by HPLC 
[8]. Iridoid glycosides (gentiopicrin and swertiamarin), flavonoids 
(isoorientin and isovitexin), and xanthones (mangiferin, isogentisin, 
isogentisin-3-O-primeveroside) have been detected previously. In 
the present study, LC-ESI-MS and HPLC techniques were used for 
the comprehensive analysis of the leaves of G. lutea collected from 
different habitats in the mountains of Montenegro.  Extracts were 
also evaluated for their antiradical and cytotoxic activities. 
Altogether, methanol extracts of fifteen G. lutea samples from 
various locations were analyzed. Identification of the compounds 
was based on chromatographic and mass spectral information, and 
the 15 identified compounds (Figure 1) are listed in Table 1.  
 
Among the analyzed samples, two chromatographic patterns could 
be observed. Samples 1-9 and 12-15 had more complex 
chromatographic profiles, with 15 characteristic peaks, whereas 
samples 10 and 11 (mountain Sinjavina) showed 10 major peaks. 
The major difference between the samples was in the secoiridoid 
group. All analyzed samples contained loganic acid (4) and 
gentiopicrin (9). Samples 1-9 and 12-15 were characterized by the 
presence of eustomorusside (2), eustomoside (3), septemfidoside (5) 
and swertiamarin (6), whereas samples 10-11 contained only 
sweroside (16) in addition. According to the literature, swertiamarin 
(6) and gentiopicrin (9) have been previously reported in G. lutea 
leaves [8]. It should be noted that swertiamarin derivatives, namely 
eustomorusside (2), eustomoside (3) and septemfidoside (5), were 
detected in G. lutea for the first time. These compounds have 
limited distribution in the genus Gentiana, having been found only 
in G. septemfida and G. olivieri until now [9, 10]. Such a 
secoiridoid profile could support the traditional usage of G. lutea 
leaves as a substitute for its roots.  
 
The polyphenol composition of G. lutea reported in our study is in 
accordance with previous reports [6,8,11]. The xanthones 
mangiferin (10), gentioside (14) and isogentisine (15) were present 
in all analyzed samples, thus indicating the common xanthones 
pattern. However, some variation in flavonoid profile was observed 
between the studied samples. Samples 1-9 and 12-15 contained 
isoorientin (12), isovitexin (13), and their O-heterosides isoorientin-
4'-O-glucoside (7), isosaponarin (8) and isoorientin-2''-O-glucoside 
(11), while in samples 10 and 11, compounds 7 and 8 were not 
detected. 
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Figure 1: Chemical structures of the identified compounds (2-16) in G. lutea leaves. 
 
Table 1: HPLC-DAD and LC-MS data of the constituents from G. lutea leaves. 
 
   DAD MS   
Peak tR (min) Compound λmax (nm) Species Mass 
Molecular 
formula 
1 1.7 Unknown 228 M-H 342.1320  
2 2.9 Eustomorusside 240 M-H 408.1406 C16H24O12 
3 6.1 Eustomoside 236 M-H 390.1202 C16H22O11 
4 7.6 Loganic acid 238 M-H 376.1367 C16H24O10 
5 9.8 Septemfidoside 240 M-H 826.2535 C32H46O21 
6 10.2 Swertiamarin 238 M-H 374.1218 C16H22O10 
7 11.2 Isoorientin-4'-O-glucoside 270, 338 M-H, 2M-H 610.1538 C27H30O16 
8 11.5 Isosaponarin 270, 326 M-H, 2M-H 594.1589 C27H30O15 
9 12.6 Gentiopicrin 242, 274 M-H 356.1111 C16H20O9 
10 12.8 Mangiferin 240, 258, 318, 366 M-H 422.0863 C19H18O11 
11 19.6 Isoorientin-2''-O-glucoside 270, 350 M-H, 2M-H 610.1543 C27H30O16 
12 20.8 Isoorientin 270, 350 M-H 448.1012 C21H20O11 
13 23.5 Isovitexin 270, 336 M-H 432.1060 C21H20O10 
14 26.9 Gentioside 236, 260, 302, 372 M-H 552.1483 C25H28O14 
15 31.6 Isogentisin 234, 258, 310, 370 M-H 258.0531 C14H10O5 
16 14.0 Sweroside 246 M-H 358.1269 C16H22O9 
 
The results of the analysis of polyphenol compounds are of interest 
taking into account that flavonoids and xanthones represent a group 
of secondary metabolites with various biological activities. The 
main C-glucoflavone, isoorientin, exhibited hepatoprotective, 
hypoglycemic, antihyperlipidemic, antiinflammatory and 
antioxidative effects [12-15]. The xanthone, mangiferin, the main 
constituent of some plants and extracts used in traditional medicine 
in many parts of the world, has been reported as a hepatoprotective, 
analgesic, anti-inflammatory and antioxidant agent [16-18]. Our 
previous studies reported antitubercular, antimicrobial and 
radioprotective activity of the aerial parts, as well as the polyphenol 
constituents (mangiferin and isogentisin) of G. lutea [19-21]. The 
main secoridoid, swertiamarin, has also been reported to possess 
hepatoprotective and antioxidant properties [22].  
 
HPLC was used for the quantification of some constituents of G. 
lutea leaf extracts, and the results are summarized in Table 2. In all 
samples, swertiamarin (6) was present in higher concentration than 
gentiopicrine (9). These compounds showed the broadest deviation 
among all the quantified compounds, differing from 1.3 to 34.7 
mg/g (6), and 0.7 to 15.2 mg/g (9). As pointed out earlier, 
swertiamarin (6) was not detected in samples 10 and 11, which 
contained  sweroside (16) instead.   The xanthones  mangiferin (10)  
Table 2: Contents of the secondary metabolites (mg/g DW) of G. lutea leaves. 
 
Sample 6 9 10 13 15 
1 9.9 ± 0.5 5.9 ± 0.3 3.4 ±0.4 2.0±0.09 0.5±0.05
2 4.6 ± 0.8 4.0 ± 0.3 3.6 ±0.3 0.6±01 0.2±0.08 
3 2.7 ± 0.2 0.8 ± 0.09 3.2 ±0.3 0.8±0.1 0.3±0.09 
4 34.7 ± 2.9 3.3 ± 0.2 2.2 ±0.2 0.7±0.06 0.1±0.02 
5 11.1 ± 1.1 4.5 ± 0.4 7.3 ±0.9 2.8±0.2 0.5±0.03 
6 26.3 ± 0.09 0.7 ± 0.09 3.6 ±0.4 0.8±0.09 1.2±0.01 
7 1.3 ± 2.1 2.4 ± 0.04 4.0 ±0.3 0.6±0.07 0.2±0.2 
8 33.1 ± 0.1 7.1 ± 0.3   4.0 ±0.2 2.4±0.09 0.2±0.05 
9 10.1 ± 3.0 3.9 ± 0.6 2.5 ±0.3 1.1±0.2 0.6±0.02 
10 n.d. 15.2 ±1.5 4.8 ±0.5 2.8±0.2 2.8±0.2 
11 n.d. 11.6 ±1.2 4.4 ±0.4 2.1±0.2 6.1±0.5 
12 2.4 ± 1.2 0.9 ± 0.3 3.0 ±0.3 0.3±0.05 0.6±0.03 
13 11.9 ± 0.2 3.2 ± 0.08 2.3 ±0.2 0.4±0.02 0.4±0.05 
14 4.0 ± 0.4 3.5 ± 0.4 3.7 ±0.3 0.5±0.03 0.6±0.07 
15 7.0 ± 0.6 3.3  ± 0.3 3.4 ±0.3 0.8±0.8 0.1±0.07 
Legend: 6, swertiamarin; 9, gentiopicrine; 10, mangiferin; 13, isovitexin; 15, 
isogentisine; n.d., not detected. 
 
and isogentisine (15) were less variable in concentration, ranging 
from 2.2 – 7.3 mg/g and 0.1 to 6.1 mg/g, respectively. The amount 
of the C-glucoflavone isovitexin (13) was the most consistent (0.3 – 
2.8 mg/g) among the samples. Our results show that the chemical 
profile of G. lutea leaves is very similar to that of the aerial parts of 
G. olivieri [10, 23], which are used in southeast Anatolia as a 
remedy for lowering blood glucose level in type-2 diabetes and as a 
component in a preparation for anaemia [24].  
 
Table 3: The contents of UV-absorbing compounds in G. lutea leaves growing at 
different altitudes (L1-L8). 
 
 L7 L1 L4 L8 L5 L6 L3 
Altitude (m) 1450 1531 1550 1580 1620 1710 1775 
10 (mg/g) 2.97 3.63 3.60 3.72 3.96 4.76 7.30 
Σ 10+13+15 (mg/g) 3.87 5.83 5.61 4.79 6.61 10.38 10.55 
 
It could be observed that the amount of mangiferin was larger in 
plants growing at higher altitudes (Table 3). A similar trend was 
noticed regarding γ-pyrones (xanthones and flavonoids); their 
amount in plants collected from Strmenica (L3, sample 5, 1775 m) 
was 2.7-fold higher than that from Kobilja glava (L7, sample 12, 
1450 m). Statistically significant correlation was observed between 
concentrations of γ-pyrones and mangiferin, and altitude (r = 0.94 
and r = 0.90, respectively, at p < 0.05).  
 
Our results are in accordance with previous findings that the 
contents of mangiferin and other UV-absorbing compounds are 
greater in plants growing at higher altitudes [25, 26].  
 
The total phenolic content and DPPH radical-scavenging activity of 
leaves of G. lutea collected from different localities are shown in 
Table 4. The total phenolics content ranged from 7.7 to 12.7 mg 
GAE/g, and IC50 for DPPH radical scavenging activity varied 
between 0.45 to 2.02 mg/mL. The relationship between total 
phenolics content and antiradical activity (expressed as reciprocal 
value of the calculated IC50) of extracts was observed with 
statistically significant correlation (r = 0.673, p < 0.05). Positive 
correlation (r = 0.696, p < 0.05) between the sum of γ-pyrones 
determined by HPLC and radical scavenging activity was also 
noticed. 
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Table 4: Total phenolic content and DPPH radical-scavenging activity of leaves of      
G. lutea. 
 
Sample Total phenolics (mg GAE/g) Σ 10+13+15 (mg/g) DPPH radical scavenging activity IC50 (mg/mL) 
1 11.5 ± 0.1 5.83 ± 0.18 0.58 ± 0.03
2 11.0 ± 0.1 4.39 ± 0.16 0.76 ± 0.02  
3 10.3 ± 0.1 4.22 ± 0.17 0.90 ± 0.01 
4 11.9 ± 0.1 3.02 ± 0.69 1.27 ± 0.04 
5 11.7 ± 0.5 10.55 ± 0.37 0.45 ± 0.02 
6 10.6 ± 0.1 5.61 ± 0.17 0.60 ± 0.03 
7 8.4 ± 0.1 4.74 ± 0.21 1.21 ± 0.03 
8 12.7 ± 0.1 6.61 ± 0.12 0.63 ± 0.03  
9 10.6 ± 0.1 4.20 ± 0.18 0.78 ± 0.19 
10 12.3 ± 0.1 10.38 ± 0.31 0.59 ± 0.02 
11 11.2 ± 0.1 12.73 ± 0.38 0.69 ± 0.02 
12 9.4 ± 0.1 3.87 ± 0.14 0.91 ± 0.03 
13 7.7 ± 0.1 3.12 ± 0.10 2.02 ± 0.07 
14 12.0 ± 0.01 4.79 ± 0.17 0.87 ± 0.03 
15 8.5 ± 0.03 4.35 ± 0.09 1.15 ± 0.03 
 
The cytotoxic activity of G. lutea leaf extracts which showed the 
highest antiradical activity, as well as gentiopicrin, mangiferin and 
isogentisin, were tested against human malignant cell lines (HeLa, 
MCF7, PC3 and LS174 cells). Cisplatin was used as a positive 
control and showed the highest growth inhibitory potency to all 
tested cells. The G. lutea extract exhibited moderate cytotoxic 
effects toward HeLa cells with an IC50 value of 41.1 µg/mL (Table 
5). As for the other cell lines, leaf extracts showed no cytotoxicity. 
All of the tested compounds exerted strong activity against HeLa 
cells, with IC50 values ranging from 5.71 to 8.82 µg/mL. Isogentisin 
showed moderate activity against MCF7, PC3 and LS174 cells, 
with similar IC50 values of 36.3, 36.2 and 39.6 µg/mL, respectively. 
Gentiopicrin and mangiferin exhibited no cytotoxicity against these 
cell lines, all IC50 values being higher than 200 µg/mL. 
 
Table 5: In vitro cytotoxic activity (IC50) of G. lutea leaf extracts and selected 
compounds (μg/mL). 
 
Sample HeLa MCF7 PC3 LS174 
Leaves  41.1 ± 1.5 >200 >200 >200 
Gentiopicrin 5.7 ± 0.4 >200 >200 >200 
Isogentisin 8.8 ± 0.9 36.3 ± 4.4 36.2 ± 1.1 39.6 ± 4.4 
Mangiferin 7.3 ± 1.2 >200 >200 >200 
Cisplatin* 0.7 ± 0.14 1.1 ± 0.1 1.4 ± 0.2 2.4 ± 0.3 
 
There are only a few reports regarding the cytotoxic activity of 
Gentiana spp. or the compounds that were tested in our study 
[27,28]. To our knowledge, this is the first report of the potent 
cytotoxic activity of gentiopicrin, mangiferin and isogentisin against 
the HeLa cell line.  
 
The present study reports a detailed phytochemical investigation of 
G. lutea leaves. Our results show that leaves contain secoiridoids 
similar to those in the roots, which indicate their usage as a bitter 
tonic. Leaves are also rich in polyphenol compounds, especially 
mangiferin and isoorientin, which are reported to exhibit various 
biological activities. Based on the content of the main active 
principles, it is reasonable to believe that the examined species 
could be also be used as a hepatoprotective, hypoglycaemic and 
anti-inflammatory agent. The results from this study might also help 
the better utilization of G. lutea aerial parts for therapeutic 
purposes, which could have a protective role for this endangered 
plant species. Promotion of this part of the plant would certainly 
reduce the pressure on the root for exploitation, which would 
directly affect the conservation of natural resources of this species. 
 
Experimental 
 
Plant material: Leaves of Gentiana lutea L. were collected at 8 
localities (L1-L8) on 7 mountains in northern Montenegro: Bihor 
(1531 m alt., L1, samples 1-3), Durmitor (1390 m alt., L2, sample 
4), Bjelasica (1775 m alt., L3, sample 5; 1450 m alt., L7, samples 
12 and 13), Prošćen (1550 m alt., L4, samples 6 and 7), Ljubišnja 
(1620 m alt., L5, samples 8 and 9), Sinjavina (1710 m alt., L6, 
samples 10 and 11) and Gutavica (1580 m alt., L8, samples 14 and 
15), during the time of flowering (from June to September 2009). 
Voucher specimens have been deposited in the herbarium at the 
Natural Museum of Montenegro, Podgorica. 
 
Sample preparation: Air-dried plant material was powdered, 
precisely weighed (1.0 g) and extracted twice with 10 mL methanol 
in an ultrasonic bath for 30 min. For HPLC and LC-MS analyses, 
extracts were filtered through a 0.45 PTFE filter prior to injection. 
 
Determination of total phenolics: The total phenolic content was 
estimated by Folin-Ciocalteu method as described by Waterman and 
Mole [29], with slight modifications. The results were expressed as 
mg of gallic acid equivalents per g dry weight (mg GAE/g DW). 
Triplicate measurements were taken and mean values were 
calculated. 
 
HPLC-DAD analysis: Analyses were carried out on an Agilent 
1200 RR HPLC instrument, with diode array detector and a reverse 
phase Zorbax SB-C18 (Agilent) analytical column (150 mm × 4.6 
mm i.d.; 5 µm particle size). The mobile phase consisted of solvent 
A (1%, v/v, solution of orthophosphoric acid in water) and solvent 
B (acetonitrile), using an elution gradient as follows: 0-5 min, 98-
90% A; 5-15 min, 90% A; 15-20 min, 90-85% A; 20-25 min, 85-
70% A; 25-30 min, 70-40% A; 30-34 min, 40-0% A. Detection 
wavelengths were set at 260 and 320 nm,  and the flow rate was 1 
mL/min. The injection volume was 5 μL and the column 
temperature was maintained at 25°C. The amounts of the 
compounds were calculated using calibration curves. The results are 
presented as mg per g dry weight. 
 
LC-MS/MS analysis: LC-ESI-MS analyses were performed on an 
Agilent MSD TOF coupled to an Agilent 1200 series HPLC, using a 
RR Zorbax Eclipse Plus C18 column (1.8 µm, 150 x 4.6 mm). The 
mobile phase A was H2O containing 0.2% HCOOH and mobile 
phase B was MeCN. The injection volume was 5 µL, and elution at 
0.995 mL/min with gradient program (0-3.02 min 10-20% B; 3.02-
6.03 min 20% B; 6.03-12.06 min 20-30% B; 12.06-18.09 min 30-
70% B; 18.09-24 min 70-38% B; 24-30 min 38-99% B; 30-33 min 
99% B; 33-34 min 99-5% B). Mass spectra were acquired using an 
Agilent ESI-MSD TOF. Drying gas (N2) flow was 12 L/min; 
nebulizer pressure was 45 psig; drying gas temperature was 350°C. 
For ESI analysis, the parameters were: capillary voltage, 4000 V; 
fragmentor, 140 V; skimmer, 60 V; Oct RF V 250 V, for negative 
modes. The mass range was from 100 to 2000 m/z. The data was 
processed with Molecular Feature Extractor and Mass Profiler 
software. 
 
DPPH radical scavenging activity: The free radical scavenging 
activity was carried out according to the procedures described 
previously [30, 31]. All test analyses were run in triplicate. Trolox 
was used as a positive control exhibiting IC50 value of 6.1 μg/mL. 
 
Cytotoxic activity: Based on the total phenolic content and 
antiradical activity, sample 5 was selected for investigation of 
cytotoxic activity on 4 human cancer cell lines. Human cervix 
adenocarcinoma HeLa cells, human breast cancer MCF7, human 
prostate cancer PC3, and human colon carcinoma LS174 cell lines 
were obtained from the American Type Culture Collection (ATCC) 
(Manassas, VA, USA). Cancer cell lines were maintained in the 
recommended Roswell Park Memorial Institute (RPMI) 1640 
medium supplemented with 100 g/L heat-inactivated (56◦C) foetal 
bovine serum (FBS), 3 mmol/L, L-glutamine, 100 mg/mL 
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streptomycin, 100 IU/mL penicillin and 25 mmol/L 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) and 
adjusted to pH 7.2 with bicarbonate solution. Cells were grown in a 
humidified atmosphere of 95% air/5% CO2 (v/v) at 37◦C. Stock 
solutions (100 mg/mL) of extract and compounds, made in DMSO, 
were dissolved in corresponding medium to the required working 
concentrations. Neoplastic HeLa (2000 cells per well), MCF7 (3000 
cells per well), PC3 cells (5000 cells per well) and LS174 cells 
(7000 cells per well) were seeded into 96-well microtitre plates; 24 
h later, after cell adherence, investigated compounds were added to 
the wells, and the final concentrations applied to target cells were 
200, 100, 50, 25 and 12.5 μg/mL. The cultures were incubated for 
72 h. 
 
The effect of extract and compounds on cancer cell survival was 
determined 72 h after the addition of extract/compounds by the 
microculture tetrazolium test (MTT) according to Mosmann [32]. 
All experiments were made in triplicate. 
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